<DOC>
	<DOCNO>NCT00000435</DOCNO>
	<brief_summary>A small protein call dnaJ peptide may help people rheumatoid arthritis ( RA ) prevent immune system cell attack tissue . The purpose study determine small amount dnaJ peptide `` re-educate '' immune cell people RA cell stop attack joint tissue .</brief_summary>
	<brief_title>dnaJ Peptide Relieving Rheumatoid Arthritis</brief_title>
	<detailed_description>Immune modulation promise new approach treatment RA . Studies show immune cell joint people early stage RA react strongly dnaJ peptide bacteria . These immune cell may also cross-react human dnaJ peptide joint cause inflammation . dnaJ may help RA `` re-educating '' immune system dampen abnormal inflammatory immune response RA . This study last 7 month . Participants randomly assign receive either dnaJ placebo mouth . At screen , participant medical history , physical , medication assessment . At screen , 6 study visit every month start treatment , 1 month follow-up , participant joint exam , blood urine collection , fill questionnaire condition .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Active rheumatoid arthritis define revised American College Rheumatology ( ACR ) 1987 criterion . Evidence active disease base least six swollen nine tender joint . Diagnosis rheumatoid arthritis less 5 year Reactivity dnaJ Agree use acceptable method contraception Able understand sign inform consent Patients take 7.5 mg prednisone disease modify agent hydrochloroquine sulfasalazine ( i.e. , gold , penicillamine , azathioprine , cyclophosphamide , methotrexate , cyclosporine , antiTNF agent ) Serum creatinine great 1.5 mg/dl SGOT le SGPT Alkaline phosphatase great 2 time age/sex adjust normal value Hematocrit le 30 Platelets less 130,000 History lymphoma Any active malignancy cancer require treatment last 5 year , except nonmelanoma skin cancer carcinoma cervix situ Medical psychiatric condition active serious infection Pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>RA</keyword>
	<keyword>Immune Modulation</keyword>
	<keyword>Oral Tolerance</keyword>
	<keyword>Peptide</keyword>
	<keyword>dnaJ</keyword>
</DOC>